• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. BD INSYTE¿ AUTOGUARD¿ BC SHIELDED IV CATHETER; INTERVASCULAR CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. BD INSYTE¿ AUTOGUARD¿ BC SHIELDED IV CATHETER; INTERVASCULAR CATHETER Back to Search Results
Catalog Number 382554
Health Effect - Clinical Code No Known Impact Or Consequence To Patient (2692)
Date of Event 08/24/2018
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event or Problem Description
It was reported that a bd insyte¿ autoguard¿ bc shielded iv catheter had sterile breach due to packaging adhesive failure.There was no report of exposure, serious injury or medical intervention.
 
Event or Problem Description
It was reported that a bd insyte¿ autoguard¿ bc shielded iv catheter had sterile breach due to packaging adhesive failure.There was no report of exposure, serious injury or medical intervention.
 
Additional Manufacturer Narrative
Investigation summary: dhr review was performed on the lot number 6042686: the lot number was manufactured on afa line 9 from february 16, 2016 thru february 18, 2016 packaged on packaging line 11 from february 19, 2016 thru march 12, 2016 review of dhr revealed all required challenge samples, set-up and in process testing was performed in accordance with the quality plans.Review disclosed two non-related qn¿s were initiated during the build of this lot that would not impact the outcome of the quality of the product relevant to the reported defect.Received one iag bc 16ga unit from lot number 6042696.Package was partially opened, but this is the basis of the complaint.The product characteristics require a minimum of 1/8¿ seal width with adhesive transfer from the top web paper to the bottom web film.This characteristic was met.The key variables that affect the packaging seal are seal transfer/width and top web adhesive presence.Both of these variables were included in the investigation.The defect stated in the description of the complaint was confirmed with the returned unit that was partially open at one end.Even though the packages were received partially opened, all the process characteristics that directly influence the seal were observed to be within specification.No anomalies were found.Conclusion(s): bd supplier (b)(4) 29lp uses a standard reinforced paper that is common to many other suppliers, but the adhesive type and application is specific to (b)(4) there is sufficient evidence to demonstrate the ot material or adhesive application is the root cause.Due to continuous issues with (b)(4), bd is moving to an alternate supplier for the top web material.Capa (b)(4) was opened to investigate the package seal integrity complaints and implement corrective actions.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD INSYTE¿ AUTOGUARD¿ BC SHIELDED IV CATHETER
Common Device Name
INTERVASCULAR CATHETER
Manufacturer (Section D)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
MDR Report Key7878166
Report Number1710034-2018-00635
Device Sequence Number2725785
Product Code FOZ
UDI-Device Identifier30382903825548
UDI-Public30382903825548
Combination Product (Y/N)N
Initial Reporter CountryAS
PMA/510(K) Number
K110443
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source foreign,health professional,o
Initial Reporter Occupation Nurse
Type of Report Initial,Followup
Report Date (Section B) 11/19/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Other
Device Expiration Date02/28/2019
Device Catalogue Number382554
Device Lot Number6042686
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/10/2018
Initial Date Received by Manufacturer 08/24/2018
Supplement Date Received by Manufacturer08/24/2018
Initial Report FDA Received Date09/14/2018
Supplement Report FDA Received Date11/20/2018
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
-
-